Document Detail

Outcome of cardiac surgery for carcinoid heart disease.
MedLine Citation:
PMID:  7829795     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The hypothesis was that cardiac surgery for symptomatic carcinoid heart disease in conjunction with adjunctive therapy could improve the long-term outlook of patients with carcinoid heart disease. BACKGROUND: Patients with carcinoid heart disease have a dismal prognosis; most die of progressive right heart failure within 1 year after onset of symptoms. Improved therapies for the systemic manifestations of the carcinoid syndrome have resulted in symptomatic improvement and prolonged survival in patients without heart disease. METHODS: Twenty-six patients with symptomatic carcinoid heart disease underwent valvular surgery. Preoperative clinical, laboratory, Doppler echocardiographic and hemodynamic factors were evaluated. The survival of the surgical group was compared with that of a control group of 40 medically treated patients. RESULTS: There were nine perioperative deaths (35%), primarily from postoperative bleeding and right ventricular failure. Of the 17 surgical survivors, 8 were alive at a mean of 28 months of follow-up. The postoperative functional class of the eight surviving patients was substantially improved. Late deaths were primarily due to hepatic dysfunction caused by metastatic disease. The only predictor of operative mortality (p = 0.03) was low voltage on preoperative electrocardiography (limb lead voltage < or = 5 mm). Predictors of late survival included a lower preoperative somatostatin requirement and a lower preoperative urinary 5-hydroxy-indoleacetic acid level. There was a trend toward increased survival for the surgical group compared with the control group. CONCLUSIONS: Because new therapies have improved survival in patients with the malignant carcinoid syndrome, cardiac involvement has become a major cause of morbidity and mortality. Valve surgery is the only definitive treatment. Although cardiac surgery carries a high perioperative mortality, marked symptomatic improvement occurs in survivors. Surgical intervention should therefore be considered when cardiac symptoms become severe.
H M Connolly; R A Nishimura; H C Smith; P A Pellikka; C J Mullany; L K Kvols
Related Documents :
8348275 - Factors predicting death, survival and functional outcome in a prospective study of ear...
24779865 - Organophosphate-pyrethroid combination pesticides may be associated with increased toxi...
24762285 - Prophylaxis in real life scenarios.
22949975 - Remifentanil used as adjuvant in general anesthesia for spinal fusion does not exhibit ...
19456855 - Two different doses of amitriptyline er in the prophylaxis of migraine: long-term resul...
11547075 - Hemostatic technique: extracapsular prostatic adenomectomy.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  25     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1995 Feb 
Date Detail:
Created Date:  1995-02-22     Completed Date:  1995-02-22     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  410-6     Citation Subset:  AIM; IM    
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Actuarial Analysis
Carcinoid Heart Disease / diagnosis,  mortality,  surgery*
Follow-Up Studies
Heart Valve Prosthesis* / mortality
Heart Valves / surgery*
Middle Aged
Survival Analysis
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Incremental prognostic value of exercise thallium-201 myocardial single-photon emission computed tom...
Next Document:  Electrocardiographic identification of increased left ventricular mass by simple voltage-duration pr...